nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—PTGS2—prostate cancer	0.358	1	CbGaD
Lornoxicam—CYP2C9—Nilutamide—prostate cancer	0.105	0.217	CbGbCtD
Lornoxicam—CYP2C9—Bicalutamide—prostate cancer	0.105	0.217	CbGbCtD
Lornoxicam—PTGS2—Etoposide—prostate cancer	0.0693	0.143	CbGbCtD
Lornoxicam—CYP2C9—Estrone—prostate cancer	0.0628	0.13	CbGbCtD
Lornoxicam—PTGS1—Etoposide—prostate cancer	0.0585	0.121	CbGbCtD
Lornoxicam—CYP2C9—Capecitabine—prostate cancer	0.0476	0.0984	CbGbCtD
Lornoxicam—CYP2C9—Estradiol—prostate cancer	0.0361	0.0745	CbGbCtD
Lornoxicam—Tenoxicam—PTGS2—prostate cancer	0.000977	0.327	CrCbGaD
Lornoxicam—Meloxicam—CYP3A4—prostate cancer	0.000711	0.238	CrCbGaD
Lornoxicam—Meloxicam—PTGS2—prostate cancer	0.000696	0.233	CrCbGaD
Lornoxicam—Piroxicam—PTGS2—prostate cancer	0.000604	0.202	CrCbGaD
Lornoxicam—CYP2C9—urine—prostate cancer	3.32e-05	0.262	CbGeAlD
Lornoxicam—PTGS2—Metabolism—PLCB2—prostate cancer	2.69e-05	0.000174	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—LRP2—prostate cancer	2.69e-05	0.000174	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—P4HB—prostate cancer	2.64e-05	0.00017	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP7B1—prostate cancer	2.64e-05	0.00017	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MTAP—prostate cancer	2.64e-05	0.00017	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—AKR1C3—prostate cancer	2.63e-05	0.00017	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PRKACB—prostate cancer	2.62e-05	0.000169	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP17A1—prostate cancer	2.59e-05	0.000167	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	2.58e-05	0.000167	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	2.58e-05	0.000166	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SRD5A1—prostate cancer	2.57e-05	0.000166	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SULT1E1—prostate cancer	2.57e-05	0.000166	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC22A1—prostate cancer	2.57e-05	0.000166	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.56e-05	0.000165	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TGFBR1—prostate cancer	2.54e-05	0.000164	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—B2M—prostate cancer	2.54e-05	0.000164	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.54e-05	0.000164	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SULT2A1—prostate cancer	2.5e-05	0.000161	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	2.5e-05	0.000161	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—RPS19—prostate cancer	2.5e-05	0.000161	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—AKR1C3—prostate cancer	2.5e-05	0.000161	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.5e-05	0.000161	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PRKACB—prostate cancer	2.48e-05	0.00016	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NCOA2—prostate cancer	2.47e-05	0.00016	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MED12—prostate cancer	2.46e-05	0.000159	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.46e-05	0.000159	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HSD17B3—prostate cancer	2.45e-05	0.000158	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ACSL4—prostate cancer	2.45e-05	0.000158	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GNG5—prostate cancer	2.44e-05	0.000158	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.42e-05	0.000156	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PPP3CA—prostate cancer	2.42e-05	0.000156	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC5A5—prostate cancer	2.36e-05	0.000152	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NCOA3—prostate cancer	2.35e-05	0.000152	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ARG2—prostate cancer	2.35e-05	0.000152	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PHGDH—prostate cancer	2.35e-05	0.000152	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—UMPS—prostate cancer	2.35e-05	0.000152	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PRKCZ—prostate cancer	2.34e-05	0.000151	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.34e-05	0.000151	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.31e-05	0.000149	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—LDHB—prostate cancer	2.3e-05	0.000149	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP2E1—prostate cancer	2.3e-05	0.000149	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CALR—prostate cancer	2.3e-05	0.000149	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NQO1—prostate cancer	2.28e-05	0.000147	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGFR4—prostate cancer	2.26e-05	0.000146	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PARP1—prostate cancer	2.26e-05	0.000146	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP3A5—prostate cancer	2.26e-05	0.000146	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—TH—prostate cancer	2.24e-05	0.000145	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HPGDS—prostate cancer	2.24e-05	0.000145	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CALCA—prostate cancer	2.23e-05	0.000144	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.23e-05	0.000144	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP2C19—prostate cancer	2.23e-05	0.000144	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP3A4—prostate cancer	2.22e-05	0.000143	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.21e-05	0.000143	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PDHA1—prostate cancer	2.18e-05	0.000141	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TCN2—prostate cancer	2.18e-05	0.000141	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—UCP3—prostate cancer	2.18e-05	0.000141	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTA3—prostate cancer	2.18e-05	0.000141	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP1B1—prostate cancer	2.18e-05	0.000141	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTT1—prostate cancer	2.18e-05	0.00014	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ACHE—prostate cancer	2.18e-05	0.00014	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP2A6—prostate cancer	2.15e-05	0.000139	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HSPA1A—prostate cancer	2.14e-05	0.000138	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.14e-05	0.000138	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GGT1—prostate cancer	2.11e-05	0.000137	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.11e-05	0.000136	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—AKR1C3—prostate cancer	2.09e-05	0.000135	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HSD3B1—prostate cancer	2.08e-05	0.000135	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC22A3—prostate cancer	2.08e-05	0.000135	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NCOA1—prostate cancer	2.08e-05	0.000134	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PRKACB—prostate cancer	2.08e-05	0.000134	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP17A1—prostate cancer	2.06e-05	0.000133	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CASP9—prostate cancer	2.06e-05	0.000133	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP19A1—prostate cancer	2.05e-05	0.000133	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.03e-05	0.000131	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.02e-05	0.000131	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TBXAS1—prostate cancer	2e-05	0.000129	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTA4—prostate cancer	2e-05	0.000129	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PRKCQ—prostate cancer	1.99e-05	0.000129	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—RXRA—prostate cancer	1.98e-05	0.000128	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NCOA2—prostate cancer	1.96e-05	0.000127	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.95e-05	0.000126	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTA2—prostate cancer	1.95e-05	0.000126	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.93e-05	0.000124	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ABCG5—prostate cancer	1.92e-05	0.000124	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SULT1A1—prostate cancer	1.92e-05	0.000124	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—COMT—prostate cancer	1.91e-05	0.000123	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTP1—prostate cancer	1.9e-05	0.000123	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGF10—prostate cancer	1.89e-05	0.000122	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTA1—prostate cancer	1.88e-05	0.000121	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC5A5—prostate cancer	1.87e-05	0.000121	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ITPR1—prostate cancer	1.87e-05	0.000121	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTO1—prostate cancer	1.86e-05	0.00012	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NAT2—prostate cancer	1.86e-05	0.00012	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HSD3B2—prostate cancer	1.86e-05	0.00012	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.84e-05	0.000119	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP2E1—prostate cancer	1.83e-05	0.000118	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NQO1—prostate cancer	1.81e-05	0.000117	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TGFBR2—prostate cancer	1.8e-05	0.000116	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.79e-05	0.000115	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—TH—prostate cancer	1.78e-05	0.000115	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PLCB2—prostate cancer	1.78e-05	0.000115	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—LRP2—prostate cancer	1.78e-05	0.000115	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP2C18—prostate cancer	1.78e-05	0.000115	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ITPR1—prostate cancer	1.77e-05	0.000114	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.77e-05	0.000114	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—TYMS—prostate cancer	1.77e-05	0.000114	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP3A4—prostate cancer	1.76e-05	0.000114	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—P4HB—prostate cancer	1.75e-05	0.000113	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTM1—prostate cancer	1.75e-05	0.000113	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP1B1—prostate cancer	1.73e-05	0.000112	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—LPL—prostate cancer	1.71e-05	0.000111	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC22A1—prostate cancer	1.7e-05	0.00011	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.68e-05	0.000108	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GGT1—prostate cancer	1.68e-05	0.000108	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SULT2A1—prostate cancer	1.66e-05	0.000107	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP1A1—prostate cancer	1.65e-05	0.000107	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NCOA1—prostate cancer	1.65e-05	0.000107	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ERCC2—prostate cancer	1.64e-05	0.000106	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP19A1—prostate cancer	1.63e-05	0.000105	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MED12—prostate cancer	1.63e-05	0.000105	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—LPL—prostate cancer	1.62e-05	0.000105	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GNG5—prostate cancer	1.62e-05	0.000104	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PDGFRB—prostate cancer	1.61e-05	0.000104	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—RXRA—prostate cancer	1.57e-05	0.000102	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NCOA3—prostate cancer	1.56e-05	0.000101	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ERCC2—prostate cancer	1.56e-05	0.0001	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—MTHFR—prostate cancer	1.54e-05	9.96e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.53e-05	9.88e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.53e-05	9.87e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ERBB3—prostate cancer	1.52e-05	9.82e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGFR2—prostate cancer	1.52e-05	9.81e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—COMT—prostate cancer	1.51e-05	9.78e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PPARA—prostate cancer	1.51e-05	9.77e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTP1—prostate cancer	1.51e-05	9.73e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HPGDS—prostate cancer	1.49e-05	9.59e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ITPR1—prostate cancer	1.48e-05	9.58e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP2C19—prostate cancer	1.48e-05	9.53e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MTHFR—prostate cancer	1.46e-05	9.44e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.46e-05	9.42e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TERT—prostate cancer	1.46e-05	9.41e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTT1—prostate cancer	1.44e-05	9.3e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ACHE—prostate cancer	1.44e-05	9.3e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP2A6—prostate cancer	1.42e-05	9.19e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CAV1—prostate cancer	1.42e-05	9.19e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.42e-05	9.16e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—TYMS—prostate cancer	1.4e-05	9.05e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HIF1A—prostate cancer	1.39e-05	9e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTM1—prostate cancer	1.39e-05	8.94e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—AKR1C3—prostate cancer	1.38e-05	8.94e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PRKACB—prostate cancer	1.38e-05	8.89e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP17A1—prostate cancer	1.36e-05	8.8e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—LPL—prostate cancer	1.36e-05	8.78e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.36e-05	8.78e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CAV1—prostate cancer	1.35e-05	8.71e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.34e-05	8.68e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP1A1—prostate cancer	1.31e-05	8.48e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ERCC2—prostate cancer	1.3e-05	8.41e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NCOA2—prostate cancer	1.3e-05	8.39e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CG—prostate cancer	1.3e-05	8.37e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—BAD—prostate cancer	1.27e-05	8.19e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC5A5—prostate cancer	1.24e-05	8e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—APC—prostate cancer	1.23e-05	7.93e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—INS—prostate cancer	1.23e-05	7.92e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MTHFR—prostate cancer	1.22e-05	7.91e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—EGF—prostate cancer	1.21e-05	7.84e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IRS1—prostate cancer	1.21e-05	7.84e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP2E1—prostate cancer	1.21e-05	7.82e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CREBBP—prostate cancer	1.2e-05	7.76e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PPARA—prostate cancer	1.2e-05	7.76e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NQO1—prostate cancer	1.2e-05	7.73e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TH—prostate cancer	1.18e-05	7.62e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—GSK3B—prostate cancer	1.18e-05	7.61e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.17e-05	7.57e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.17e-05	7.54e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—INS—prostate cancer	1.16e-05	7.51e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.16e-05	7.5e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.15e-05	7.41e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CD—prostate cancer	1.14e-05	7.36e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CREBBP—prostate cancer	1.14e-05	7.35e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CAV1—prostate cancer	1.13e-05	7.29e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GGT1—prostate cancer	1.11e-05	7.18e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NCOA1—prostate cancer	1.09e-05	7.07e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MAP2K1—prostate cancer	1.09e-05	7.02e-05	CbGpPWpGaD
Lornoxicam—PTGS1—prostate gland—prostate cancer	1.09e-05	0.086	CbGeAlD
Lornoxicam—PTGS2—Disease—PIK3CD—prostate cancer	1.08e-05	6.97e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.08e-05	6.97e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.08e-05	6.97e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NOS3—prostate cancer	1.08e-05	6.95e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SERPINE1—prostate cancer	1.07e-05	6.9e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—RXRA—prostate cancer	1.04e-05	6.72e-05	CbGpPWpGaD
Lornoxicam—PTGS2—prostate gland—prostate cancer	1.04e-05	0.0822	CbGeAlD
Lornoxicam—PTGS2—Disease—FGF2—prostate cancer	1.03e-05	6.68e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CG—prostate cancer	1.03e-05	6.64e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NOS3—prostate cancer	1.02e-05	6.58e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.01e-05	6.54e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—COMT—prostate cancer	1e-05	6.48e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTP1—prostate cancer	9.98e-06	6.45e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CB—prostate cancer	9.93e-06	6.41e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—JAK2—prostate cancer	9.91e-06	6.4e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTGS2—prostate cancer	9.84e-06	6.35e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ITPR1—prostate cancer	9.82e-06	6.34e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—INS—prostate cancer	9.74e-06	6.29e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MDM2—prostate cancer	9.67e-06	6.25e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.66e-06	6.24e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CREBBP—prostate cancer	9.54e-06	6.16e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ERBB2—prostate cancer	9.54e-06	6.16e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PIK3CB—prostate cancer	9.41e-06	6.08e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TYMS—prostate cancer	9.28e-06	5.99e-05	CbGpPWpGaD
Lornoxicam—PTGS1—seminal vesicle—prostate cancer	9.19e-06	0.0727	CbGeAlD
Lornoxicam—CYP2C9—Metabolism—GSTM1—prostate cancer	9.17e-06	5.92e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CD—prostate cancer	9.04e-06	5.84e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—LPL—prostate cancer	9.01e-06	5.81e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CDKN1B—prostate cancer	8.83e-06	5.7e-05	CbGpPWpGaD
Lornoxicam—PTGS2—seminal vesicle—prostate cancer	8.79e-06	0.0695	CbGeAlD
Lornoxicam—CYP2C9—Metabolism—CYP1A1—prostate cancer	8.7e-06	5.62e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ERCC2—prostate cancer	8.63e-06	5.57e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTEN—prostate cancer	8.58e-06	5.54e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NOS3—prostate cancer	8.54e-06	5.51e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CTNNB1—prostate cancer	8.34e-06	5.39e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—EP300—prostate cancer	8.18e-06	5.28e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CDKN1A—prostate cancer	8.15e-06	5.26e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PTEN—prostate cancer	8.13e-06	5.25e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MTHFR—prostate cancer	8.11e-06	5.23e-05	CbGpPWpGaD
Lornoxicam—PTGS1—epithelium—prostate cancer	7.99e-06	0.0632	CbGeAlD
Lornoxicam—CYP2C9—Metabolism—PPARA—prostate cancer	7.95e-06	5.14e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CB—prostate cancer	7.88e-06	5.09e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—EP300—prostate cancer	7.76e-06	5.01e-05	CbGpPWpGaD
Lornoxicam—PTGS2—epithelium—prostate cancer	7.63e-06	0.0604	CbGeAlD
Lornoxicam—PTGS2—Disease—SRC—prostate cancer	7.54e-06	4.87e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CAV1—prostate cancer	7.48e-06	4.83e-05	CbGpPWpGaD
Lornoxicam—PTGS1—renal system—prostate cancer	7.41e-06	0.0586	CbGeAlD
Lornoxicam—PTGS2—Disease—STAT3—prostate cancer	7.27e-06	4.7e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.15e-06	4.61e-05	CbGpPWpGaD
Lornoxicam—PTGS2—renal system—prostate cancer	7.08e-06	0.056	CbGeAlD
Lornoxicam—PTGS2—urethra—prostate cancer	6.96e-06	0.055	CbGeAlD
Lornoxicam—CYP2C9—Metabolism—PIK3CG—prostate cancer	6.81e-06	4.4e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PTEN—prostate cancer	6.81e-06	4.4e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MYC—prostate cancer	6.76e-06	4.36e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TGFB1—prostate cancer	6.74e-06	4.35e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—EGFR—prostate cancer	6.61e-06	4.27e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—EP300—prostate cancer	6.5e-06	4.19e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—INS—prostate cancer	6.45e-06	4.16e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CREBBP—prostate cancer	6.32e-06	4.08e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—KRAS—prostate cancer	6.25e-06	4.03e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CA—prostate cancer	6.05e-06	3.91e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3CD—prostate cancer	5.99e-06	3.87e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PIK3CA—prostate cancer	5.74e-06	3.7e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NOS3—prostate cancer	5.66e-06	3.65e-05	CbGpPWpGaD
Lornoxicam—PTGS2—bone marrow—prostate cancer	5.35e-06	0.0424	CbGeAlD
Lornoxicam—CYP2C9—Metabolism—PIK3CB—prostate cancer	5.22e-06	3.37e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTGS2—prostate cancer	5.17e-06	3.34e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IL6—prostate cancer	5.08e-06	3.28e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—AKT1—prostate cancer	4.94e-06	3.19e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CA—prostate cancer	4.81e-06	3.1e-05	CbGpPWpGaD
Lornoxicam—PTGS1—testis—prostate cancer	4.79e-06	0.0379	CbGeAlD
Lornoxicam—PTGS2—Disease—AKT1—prostate cancer	4.69e-06	3.03e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTEN—prostate cancer	4.51e-06	2.91e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—EP300—prostate cancer	4.3e-06	2.78e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—AKT1—prostate cancer	3.93e-06	2.53e-05	CbGpPWpGaD
Lornoxicam—PTGS1—lymph node—prostate cancer	3.47e-06	0.0275	CbGeAlD
Lornoxicam—PTGS2—lymph node—prostate cancer	3.32e-06	0.0262	CbGeAlD
Lornoxicam—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.18e-06	2.05e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—AKT1—prostate cancer	2.6e-06	1.68e-05	CbGpPWpGaD
